FGF21 may target the vascular system, protecting against atherosclerosis by inducing adiponectin to inhibit neointima formation and inflammation and suppressing hepatic cholesterol synthesis to reduce hypercholesterolemia (Rusu et al., 2017; Lin et al., 2015). This evidence concerns the gene ADIPOQ and atherosclerosis.